Abstract
Serum cholesterol and triglyceride levels were estimated and oral glucose tolerance tests performed on 16 patients with carcinoma of the prostate before treatment and while receiving stilboestrol in doses of 1 mg, 7·5 mg, and 15 mg daily and conjugated equine oestrogens (Premarin) 15 mg daily. Serum triglyceride levels were greater than 170 mg/100 ml in nearly all the patients while receiving Premarin or stilboestrol 7·5 mg and 15 mg daily. In six out of 10 patients who were given stilboestrol 1 mg daily the serum triglycerides remained within the normal range. No significant effects on serum cholesterol levels or glucose tolerance tests were observed with the various oestrogen regimens. The results support previous suggestions that a daily dose of 1 mg of stilboestrol should be regularly used in the treatment of carcinoma of the prostate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boyns D. R., Crossley J. N., Abrams M. E., Jarrett R. J., Keen H. Oral glucose tolerance and related factors in a normal population sample. I. Blood sugar, plasma insulin, glyceride, and cholesterol measurements and the effects of age and sex. Br Med J. 1969 Mar 8;1(5644):595–598. doi: 10.1136/bmj.1.5644.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Byar D. P. Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group. Bull N Y Acad Med. 1972 Jun;48(5):751–766. [PMC free article] [PubMed] [Google Scholar]
- Elkeles R. S., Hampton J. R., Mitchell J. R. Effect of oestrogens on human platelet behaviour. Lancet. 1968 Aug 10;2(7563):315–318. doi: 10.1016/s0140-6736(68)90528-x. [DOI] [PubMed] [Google Scholar]
- Franey R. J., Amador E. Serum cholesterol measurement based on ethanol extraction and ferric chloride-sulfuric acid. Clin Chim Acta. 1968 Aug;21(2):255–263. doi: 10.1016/0009-8981(68)90135-6. [DOI] [PubMed] [Google Scholar]
- Hazzard W. R., Spiger M. J., Bagdade J. D., Bierman E. L. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N Engl J Med. 1969 Feb 27;280(9):471–474. doi: 10.1056/NEJM196902272800904. [DOI] [PubMed] [Google Scholar]
- Kaplan L. Cancer of the prostate:estrogen therapy: natural conjugated estrogen vs. Stillbestrol: A point of view. Rev Surg. 1968 Sep-Oct;25(5):323–329. [PubMed] [Google Scholar]
- Kontturi M., Sotaniemi E. Effect of estrogen on the serum cholesterol and triglyceride levels of prostatic cancer patients. J Urol. 1971 Jun;105(6):847–849. doi: 10.1016/s0022-5347(17)61644-6. [DOI] [PubMed] [Google Scholar]
- Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
- ROBINSON R. W., HIGANO N., COHEN W. D. Long-term effects of high-dosage estrogen therapy in men with coronary heart disease. J Chronic Dis. 1963 Feb;16:155–161. doi: 10.1016/0021-9681(63)90092-4. [DOI] [PubMed] [Google Scholar]
- Wynn V., Doar J. W. Some effects of oral contraceptives on carbohydrate metabolism. Lancet. 1966 Oct 1;2(7466):715–719. doi: 10.1016/s0140-6736(66)92978-3. [DOI] [PubMed] [Google Scholar]